
Recently, I submitted my original pathology for a genomic test designed to estimate whether I would benefit from extending endocrine therapy beyond five years.
That tiny daily pill, Arimidex, has been a constant companion. It has been an important part of my treatment—but also, literally and figuratively, a hard pill to swallow.
The test results gave me a gift I never expected. After reviewing them with my doctor, I learned that I could stop taking Arimidex and close that chapter.
This is big.
I was originally told 10 years. Now, at the five-year mark, I get to close the medicine cabinet and open something new.
Reaching five years is an important milestone. I am still a survivor, still moving forward and deeply grateful for the research and medical progress that made this moment possible.
In honor of this milestone, I’m heading to Dallas in October for the Susan G. Komen 3-Day!
I’m walking not only for myself, but for those who are still in treatment, those just beginning and those holding space for someone they love.
I walk for life.
For breath.
For every step we take after the storm.
When I originally shared this post, I was raising money to support breast cancer research, patient services, advocacy and community health. Every donation and encouraging message helped carry me toward those 60 miles.
Update: I completed the Dallas/Fort Worth 3-Day in October 2025. I remain deeply grateful to everyone who donated, encouraged me and followed the journey. Our team is now registered for the Tampa 3-Day in February 2028.
With love in my heart and rhythm in my stride,
Lisa

